Evaluation of Changes in Visual Acuity in Patients With Diabetic Macular Edema (DME) Starting Treatment With an Approved Anti-VEGF Therapy

Conditions:   Ophthalmology;   Macular Edema;   Macular Degeneration
Intervention:   Drug: Ranibizumab (or other DME treatment)
Sponsors:   Bayer;   Bayer;   Regeneron Pharmaceuticals
Recruiting – verified September 2013

Leave a Reply

You can use these HTML tags

<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <s> <strike> <strong>




twenty − fourteen =